Source: Annual Congress 2006 - Spirometric assessment of lung pathophysiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Gennimata, A. Chronaiou, E. Kosmas, T. Panomitrou, A. Koutsoukou, N. G. Koulouris (Athens, Greece). Role of bronchodilatation in staging severity of patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 1219

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of bronchodilator responses in patients with advanced COPD Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001 Clinical assessment and staging of COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 The GOLD staging system has no discriminatory capacity versus chronic comorbidities in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020 The effect preoperative intervention with long-acting bronchodilator for untreated patients with obstructive lung disease Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Impact of the nutritional status on pulmonary function in COPD patients Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013